Record Particulate Matter Events Observed During Filtration Processes

Document All Particulate Matter Events During Filtration Activities

Remember: Always record particulate matter incidents observed during filtration — even isolated occurrences must be documented and investigated.

Why This Matters in GMP

Filtration is a critical control step in sterile and non-sterile pharmaceutical manufacturing. It is often the final physical barrier against microbial and particulate contamination. Observing particulate matter during or after filtration indicates a possible breach in the filter system, contamination of feed solution, or degradation of equipment — all of which may compromise product quality. Unrecorded or uninvestigated particles pose serious risks to product safety and violate data integrity principles.

Also Read: Managing Contamination Risk During Equipment Maintenance and Calibration

Imagine a scenario where visual particles are seen during 0.22-micron filtration, but the operator assumes they are harmless air bubbles and proceeds without documenting them. If these particles are later linked to a patient complaint or adverse event, failure to document will result in loss of traceability and regulatory repercussions. GMP culture demands full transparency and accountability, especially during high-risk operations such as filtration.

Regulatory and Compliance Implications

21 CFR Part 211.100 requires all production processes to be documented and deviations to be investigated. EU GMP Annex 1 mandates filtration integrity and encourages real-time observation and

control of sterile processes. WHO GMP stresses the importance of documenting anomalies, especially those that may indicate contamination or process control failure.

Also Read: Never Bring External Tools into Grade A/B GMP Areas Without Qualification

Regulatory auditors expect to see complete batch records that include filtration logs, inline observations, and any anomaly reporting. Missing entries or unexplained anomalies during filtration may be cited as critical observations. If batch failure or complaints arise and no particulate observations are available, it suggests poor documentation practices and potential falsification. In worst cases, it may lead to product recalls, import bans, or site warning letters.

Implementation Best Practices

Train production and QA personnel to monitor and log visual checks during and after filtration. Include specific fields in filtration logbooks to capture particulate observations, filter pressure differentials, and corrective actions taken. Implement real-time visual aids such as illuminated viewing panels or cameras for continuous observation.

Also Read: Integrating HVAC, Utilities and Cleaning Programs Into a Single Contamination Strategy

Define clear SOPs for documenting particles — including size, appearance, timing, and location — and procedures for immediate escalation. Link all such records to batch deviation logs and trigger risk-based investigations. Include particulate monitoring outcomes in batch release decisions and product quality reviews.

Regulatory References

– 21 CFR Part 211.100 – Written procedures; deviations
– EU GMP Annex 1 – Manufacture of sterile medicinal products
– WHO TRS 961, Annex 4 – Documentation practices in GMP
– PDA TR #26 – Sterilizing Filtration of Liquids